“…Hereby the use of bio membranereactors and biocatalysts (enzymes) can be differentiated. 68 For example, biological conversion of methane to methanol, 69,70 the synthesis of petroleum-like hydrocarbons 71 or biofuels from microalgae 72 could be achieved. Currently, there are several challenges that need to be addressed, such as dissolving CO 2 in or poisoning of the used solution.…”
“…Hereby the use of bio membranereactors and biocatalysts (enzymes) can be differentiated. 68 For example, biological conversion of methane to methanol, 69,70 the synthesis of petroleum-like hydrocarbons 71 or biofuels from microalgae 72 could be achieved. Currently, there are several challenges that need to be addressed, such as dissolving CO 2 in or poisoning of the used solution.…”
“…As exemplied by the 20Z-pMMO EXAFS study and despite the increasing evidence that pMMO contains only mononuclear copper sites, researchers in this eld have been unable to account for the fact that EXAFS analyses of multiple pMMO samples and recombinant constructs, performed by multiple investigators working independently, consistently measured a short distance ($2.5-2.7Å) Cu-Cu scattering interaction. 15,16,[18][19][20][24][25][26][27] In order to advance the mechanistic understanding of the enzyme, the previous EXAFS studies must collectively be reconciled with themselves and with the growing body of experimental evidence indicating exclusively monocopper centers in pMMO. Herein, we rst revisit the Cu XAS of pMMO to understand how various samples could have very similar XAS spectra and yet different copper oxidation state distributions based on EPR.…”
The enzymatic conversion of the greenhouse gas, methane, to a liquid fuel, methanol, is performed by methane monooxygenases (MMOs) under mild conditions. The copper stoichiometry of particulate MMO (pMMO) has...
“…In our experience 5 , 6 , it is very difficult to biochemically or structurally determine if a novel Cu-protein is an enzyme or a Cu-chelator. The ongoing scientific controversy regarding the active site of pMMO 7 – 9 is reflecting the same problem. Absence of activity in metallo-enzyme assays can in principle be due to a number of factors including lack of suitable reducing agent or substrate.…”
Lytic polysaccharide monooxygenase (LPMO) and copper binding protein CopC share a similar mononuclear copper site. This site is defined by an N-terminal histidine and a second internal histidine side chain in a configuration called the histidine brace. To understand better the determinants of reactivity, the biochemical and structural properties of a well-described cellulose-specific LPMO from Thermoascus aurantiacus (TaAA9A) is compared with that of CopC from Pseudomonas fluorescens (PfCopC) and with the LPMO-like protein Bim1 from Cryptococcus neoformans. PfCopC is not reduced by ascorbate but is a very strong Cu(II) chelator due to residues that interacts with the N-terminus. This first biochemical characterization of Bim1 shows that it is not redox active, but very sensitive to H2O2, which accelerates the release of Cu ions from the protein. TaAA9A oxidizes ascorbate at a rate similar to free copper but through a mechanism that produce fewer reactive oxygen species. These three biologically relevant examples emphasize the diversity in how the proteinaceous environment control reactivity of Cu with O2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.